Potent and Orally Bioavailable Antiplatelet Agent, PLD-301, with the Potential of Overcoming Clopidogrel Resistance

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|3|250-254

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.3, 2016-03, pp. : 250-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aspirin and Antiplatelet Agent Resistance: Implications for Prevention of Secondary Stroke

By Greer David M.  

CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. : 1027-1040

Adis International

Access to resources Recommend Favorite

Preclinical Efficacy and Safety Pharmacology of SUN-1334H, a Potent Orally Active Antihistamine Agent

By Mandhane Sanjay N.   Ayer Upendra B.   Midha Ajay S.   Chitturi Trinadha Rao   Rajamannar Thennati  

Drugs in R&D, Vol. 9, Iss. 2, 2008-01 ,pp. : 93-112

Adis International

Access to resources Recommend Favorite

Orally Bioavailable Cathepsin K Inhibitors with Pyrrolopyrimidine Scaffold

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 7, 2010-01 ,pp. : 752-766

Bentham Science Publishers

Access to resources Recommend Favorite

Omeprazole reduces antiplatelet action of clopidogrel

By  

Inpharma, Vol. 1, Iss. 1622, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Overcoming Treatment Resistance in HER2-Positive Breast Cancer: Potential Strategies

By Puglisi Fabio   >  

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1175-1193

Adis International

Access to resources Recommend Favorite